149 related articles for article (PubMed ID: 35147042)
21. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
[TBL] [Abstract][Full Text] [Related]
22. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.
Clay MR; Martinez AP; Weiss SW; Edgar MA
Am J Surg Pathol; 2016 Dec; 40(12):1647-1652. PubMed ID: 27508976
[TBL] [Abstract][Full Text] [Related]
23. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
24. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263
[No Abstract] [Full Text] [Related]
25. Expanding the differential of cutaneous epithelioid tumors: A case of dedifferentiated liposarcoma with epithelioid features involving the skin, with review of the literature.
Chambers M; Badin DJ; Sriharan AA; Linos KD
J Cutan Pathol; 2020 Jun; 47(6):554-560. PubMed ID: 31995237
[TBL] [Abstract][Full Text] [Related]
26. MDM2-positive papillary sarcomatoid renal cell carcinoma: a potential diagnostic pitfall.
Jeruc J; Čugura T; Tomažič A; Boštjančič E
Virchows Arch; 2020 May; 476(5):783-786. PubMed ID: 31732813
[TBL] [Abstract][Full Text] [Related]
27. Synchronous Renal Dedifferentiated Liposarcoma and Retroperitoneal Well-Differentiated Liposarcoma: A Case Report With Literature Review.
Nie L; Chen X; Gong J; Zhang M; Xu M; Chen N; Zhou Q
Int J Surg Pathol; 2021 Sep; 29(6):667-671. PubMed ID: 33355009
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and management challenges for MDM2-, CDK4-negative fatty tumors of the retroperitoneum.
Silverstein ML; Kalof AN; Kurchena KC; Harlow SP; Lemos DF; Cintolo-Gonzalez JA
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1137-1144. PubMed ID: 33550433
[TBL] [Abstract][Full Text] [Related]
29. Retroperitoneal lipomatous angiomyolipoma associated with amyloid deposition masquerading as well-differentiated liposarcoma.
Shimada S; Harada H; Ishizawa K; Hirose T
Pathol Int; 2006 Oct; 56(10):638-41. PubMed ID: 16984623
[TBL] [Abstract][Full Text] [Related]
30. Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis.
de Vreeze RS; de Jong D; Koops W; Nederlof PM; Ariaens A; Haas RL; van Coevorden F
Int J Cancer; 2011 Feb; 128(4):778-86. PubMed ID: 20473880
[TBL] [Abstract][Full Text] [Related]
31. Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/ well differentiated liposarcoma.
Machado I; Vargas AC; Maclean F; Llombart-Bosch A
Pathol Res Pract; 2022 Apr; 232():153839. PubMed ID: 35303521
[TBL] [Abstract][Full Text] [Related]
32. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR
Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
[TBL] [Abstract][Full Text] [Related]
33. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
34. Well-differentiated liposarcoma primary from thymic stroma: Case report and literature review.
Furlan K; Miller I; Rohra P; Mir F; Ocampo Gonzalez FA; Gattuso P
Exp Mol Pathol; 2020 Oct; 116():104517. PubMed ID: 32791064
[TBL] [Abstract][Full Text] [Related]
35. Well-Differentiated Liposarcoma With Hibernoma-Like Morphology.
Hallin M; Schneider N; Thway K
Int J Surg Pathol; 2016 Oct; 24(7):620-2. PubMed ID: 27272683
[TBL] [Abstract][Full Text] [Related]
36. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
[TBL] [Abstract][Full Text] [Related]
37. Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
Alshenawy H
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1073-81. PubMed ID: 23529275
[TBL] [Abstract][Full Text] [Related]
38. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
[TBL] [Abstract][Full Text] [Related]
39. [Giant lipomas or retroperitoneal liposarcomas? Controversies in their diagnosis and treatment].
Fernández Hernández JÁ; Navarro-Barrios Á; Gil Vázquez PJ; Gil JE; Varona Garcíal L; López Motos D; Fernández Selles C; Nieto G; Frutos Bernal MD; Torres Salmerón G; Soria Cogollos T
Rev Esp Patol; 2021; 54(2):75-84. PubMed ID: 33726894
[TBL] [Abstract][Full Text] [Related]
40. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.
Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
